1. Aflatoxin B1, administered in vivo, inhibits the incorporation of [14C]orotic acid in vivo into rat liver nuclei, and also inhibits both Mg2+-and Mn2+-dependent RNA polymerase activities in nuclei assayed in vitro. 2. Aflatoxin B1 inhibits the cortisolinduced increase in incorporation of [14C]leucine in vivo, but does not affect the control value of this activity. 3. Aflatoxin B1 administered in vivo inhibits the increase in nuclear Mg2"-dependent RNA polymerase activity, assayed in vitro, which results from the treatment with cortisol. 4. Adrenalectomy causes a decrease in Mg2+-dependent RNA polymerase activity. The effect on this enzymic activity of adrenalectomy plus treatment with aflatoxin B1 is no greater than that of treatment with aflatoxin B1 alone. 5. These results suggest that the inhibition of cortisol-stimulated biochemical pathways by aflatoxin B1 is due to an inhibition of cortisol-stimulated RNA synthesis. 6. The cytoplasmic action of aflatoxin is thought to be due to a competition for receptor sites on the endoplasmic reticulum between steroid hormones and aflatoxin Bl. No evidence was obtained for a similar competition for nuclear receptor sites between [3H]cortisol and aflatoxin B1. 7. No differences were observed between the activities of RNA polymerase preparations solubilized from control or aflatoxin-inhibited nuclei. 8. No differences in 'melting' profiles were observed between DNA and chromatin preparations isolated from control nuclei or from aflatoxin-inhibited nuclei. 9. It is suggested that aflatoxin B1 exerts its effect on RNA polymerase by decreasing the template capacity of the chromatin and that the aflatoxin 'target' area of the chromatin includes that region which is stimulated by cortisol. This process, however, does not involve inhibiting the movement of cortisol from the outside of the hepatic cell to the nuclear chromatin.
1. Aflatoxin B1, administered in vivo, inhibits the incorporation of [14C] orotic acid in vivo into rat liver nuclei, and also inhibits both Mg2+-and Mn2+-dependent RNA polymerase activities in nuclei assayed in vitro. 2. Aflatoxin B1 inhibits the cortisolinduced increase in incorporation of [14C] leucine in vivo, but does not affect the control value of this activity. 3. Aflatoxin B1 administered in vivo inhibits the increase in nuclear Mg2"-dependent RNA polymerase activity, assayed in vitro, which results from the treatment with cortisol. 4. Adrenalectomy causes a decrease in Mg2+-dependent RNA polymerase activity. The effect on this enzymic activity of adrenalectomy plus treatment with aflatoxin B1 is no greater than that of treatment with aflatoxin B1 alone. 5. These results suggest that the inhibition of cortisol-stimulated biochemical pathways by aflatoxin B1 is due to an inhibition of cortisol-stimulated RNA synthesis. 6. The cytoplasmic action of aflatoxin is thought to be due to a competition for receptor sites on the endoplasmic reticulum between steroid hormones and aflatoxin Bl. No evidence was obtained for a similar competition for nuclear receptor sites between [3H]cortisol and aflatoxin B1. 7. No differences were observed between the activities of RNA polymerase preparations solubilized from control or aflatoxin-inhibited nuclei. 8. No differences in 'melting' profiles were observed between DNA and chromatin preparations isolated from control nuclei or from aflatoxin-inhibited nuclei. 9. It is suggested that aflatoxin B1 exerts its effect on RNA polymerase by decreasing the template capacity of the chromatin and that the aflatoxin 'target' area of the chromatin includes that region which is stimulated by cortisol. This process, however, does not involve inhibiting the movement of cortisol from the outside of the hepatic cell to the nuclear chromatin.
The administration ofcorticosteroids to rats results in a stimulation of the activities of several liver enzymes, including tryptophan pyrrolase (Feigelson et al., 1962) . Unlike the induction of tryptophan pyrrolase by its substrate, the induction by corticosteroids can be inhibited by actinomycin D (Greengard & Acs, 1962) , which selectively inhibits nuclear RNA synthesis. The induction of tryptophan pyrrolase by corticosteroids has therefore been presumed to occur as a result of an effect on RNA synthesis (Feigelson et al., 1962) . Like actinomycin D, the potent liver toxin and carcinogen aflatoxin B1 also inhibits both the induction of tryptophan pyrrolase by corticosteroids (Wogan & Friedman, 1968) and rat liver RNA synthesis (Wogan, 1969; Clifford & Rees, 1967a) , and is without effect on the induction of tryptophan pyrrolase by its substrate (Wogan & Friedman, 1968) . Actinomycin D is known to exert its inhibitory effect on RNA synthesis by reacting with the DNA template (Reich & Goldberg, 1964) and the apparently close similarities between many of the biochemical effects of aflatoxin B1 and actinomycin D have reasonably been presumed to be due Vol. 130 to similar mechanisms of action (Bernhard et al., 1965; Sporn et al., 1966) . However, certain important differences do exist between the actions of aflatoxin B1 and actinomycin D on liver, in particular the failure of actinomycin D to produce liver necrosis or hepatomas (Wogan, 1969) . This suggests that the mechanism of action of aflatoxin B1 on liver cells must differ in some respects from that of actinomycin D, which is further indicated by the failure of aflatoxin B1 to inhibit RNA polymerase activity in isolated nuclei, in contrast to actinomycin D, which is an effective inhibitor ofthe activity both in vivo and in vitro (Edwards & Wogan, 1970) . It thus appeared that the mechanism of action of aflatoxin B1 in liver nuclei might be more complex than simple binding to DNA and that other possible mechanisms should be investigated. Williams & Rabin (1969) 
Materials and Methods

Animals
Male rats of the Wistar-derived Porton strain, weighing 140-160g, were maintained on MRC diet 41B (Bruce & Parkes, 1956) . Aflatoxin B1 was administered intraperitoneally in solution in dimethylsulphoxide ('special for spectroscopy' grade) at a dosage of 3.5mg/kg (unless otherwise stated). This is 50% of the oral LD50 (Butler, 1964) . The present studies were, in the main, carried out over short time-periods, and during this period of up to 6h after dosing the observable changes in liver structure are dislocation ofribosomes from the rough endoplasmic reticulum, vesiculation of the roughendoplasmic-reticulum cisternae and the formation of nucleolar 'caps' (Butler, 1971) . At the dosage used, periportal necrosis was evident from 12h after dosing, and occasional deaths were encountered in longerterm studies. Cortisol acetate suspended in 0.88% NaCl was administered intraperitoneally at a dosage of 50mg/kg. Control animals received injections of the appropriate vehicles. Bilateral adrenalectomies were carried out under ether anaesthesia, the skin incisions being closed with suture clips. Animals were given 1 % NaCl as drinking water and used 5 days after the operations. Animals were killed by cervical dislocation, exsanguinated and the livers removed and rapidly chilled on ice.
Chemicals
Aflatoxin B1 was separated from a mixture of aflatoxin B1, B2, G1 and G2 (supplied by the Microbiological Research Establishment, Porton, Wilts., U.K.) by a modification of the alumina column method of Steyn (1970) 
Chemical analyses
Protein was determined by the method of Lowry et al. (1951) with bovine serum albumin as standard. DNA was determined by the method of Giles & Myers (1965) with calf thymus DNA as standard. Portions (0.5ml) of homogenates or isolated nuclei were washed three times with ice-cold 5 % (w/v) trichloroacetic acid. RNA was determined spectrophotometrically after hydrolysing the acid-insoluble residues with 1M-KOH at 37°C for 16h, acidifying with 0.5M-HC104 and clarifying by centrifuging. The extinction ofthe supernatant was measured at 260nm, the extinction coefficient used being 34.2mg of RNA mli1 * cm- (Scott et al., 1956) .
Radioactivity was determined in a Packard TriCarb liquid-scintillation spectrometer, count rates being converted into d.p.m. by means of internal standardization.
Incorporation of [14C]orotic acid and [14C]leucine in vivo
Groups of three animals were used. In the ["4C]-orotic acid-incorporation experiments, rats were injected intraperitoneally with 2.5,uCi of [(4C]orotic acid in 0.88 % NaCl (1 ml) 15min before being killed. Livers were removed and chilled on ice. All subsequent procedures were carried out at 0-40C. Portions (4g) of pooled livers were homogenized in lOml of 0.25 M-sucrose-1 mM-MgCl2 by using a Potter-Elvehjem homogenizer fitted with a Teflon pestle (TRI-R instruments; Camlab, Cambridge, Cambs., U.K.). The homogenate was diluted with 2ml of water and a purified nuclear fraction was isolated essentially by the method of Widnell & Tata (1964) . RNA present in residues after washing nuclei three times with ice-cold 5 % trichloroacetic acid was hydrolysed in 1 M-KOH as described above. Portions (100l,) of the hydrolysate were taken for spectrophotometric measurement of the RNA content.
Other samples (200,ul) were placed in radioactivitycounting vials and, after careful neutralization, 10ml of dioxan-based scintillator (Bray, 1960) Tryptophan pyrrolase assay Tryptophan pyrrolase activity in liver was assayed by the method of Feigelson & Greengard (1961) in unfractionated homogenates. Preliminary experiments were carried out to determine the time required to reach the linear phase ofenzymic activity, and subsequent assays were carried out during the linear phase.
RNA polymerase assay DNA-dependent RNA polymerase activity (nucleoside triphosphate-RNA nucleotidyltransferase, EC 2.7.7.6), both that activated by Mg2+ and that activated by Mn2+-(NH4)2SO4, were assayed in intact nuclei essentially by the method of Widnell & Tata (1966) , with [3H]UTP as the labelled substrate.
The nuclei were isolated from liver homogenates by the method described above. Each nuclear preparation was checked for freedom from gross contamination with other subcellular components by phasecontrast microscopy.
RNA polymerase activity was also assayed after solubilization from isolated nuclei by the method of Jacob et al. (1968) . In these experiments the nuclei were isolated by homogenizing the liver in 2.2M-sucrose-10mM-magnesium acetate-0.25mM-spermine (Busch et al., 1967) . The incubation medium contained, in a total volume of 0.75 ml: calf thymus DNA, 50, ug; pH8.0, 40, umol; MgCl2, 2, umol; MnC12, 1.5, umol; NaF, 2 umol; cysteine, 7, umol; spermine, 2, umol; ATP, 0.35, umol; CTP and GTP, 0.3, umol; UTP, 0.07, umol;  [3H]UTP, 0.2nmol; saturated (NH4)2SO4 soln., 15,ul; solubilized polymerase enzyme, 200,ul. Assays were preincubated in the absence of [3H]-UTP and (NH4)2SO4 for 4min at 37°C. After addition of these substances, the incubations were continued Vol. 130 for 20min. The incubations were terminated by cooling the tubes in ice, and after addition of 0.1 ml of a solution containing 50nmol of unlabelled UTP and 0.1 mg of bovine serum albumin, the nucleic acids and protein were precipitated by adding 3 ml of icecold 10 % (v/v) trichloroacetic acid containing 0.04M-sodium pyrophosphate. The precipitate was centrifuged down, and washed with 3 x 3 ml of ice-cold 5 % (w/v) trichloroacetic acid containing 0.04M-sodium pyrophosphate and then 2x3ml of ethanol-ether (3:1, v/v). Samples were hydrolysed in lml of 5% (v/v) HC104 at 90°C for 15min. After cooling and centrifuging, samples (200 ,ul) were placed in counting vials, carefully neutralized, and the dioxanbased scintillator (lOml) was added. Radioactivity was then determined as described above. Each enzyme preparation used was checked for saturation by the 5O0,g of DNA present in the assay medium.
Subcellular distribution of [3H]cortisol
Animals were injected intraperitoneally with [3H]-cortisol. After the appropriate interval, the animals were killed and bled, and livers removed and placed on ice. The subsequent procedures were based on those of Beato et al. (1969) and were all carried out at 0-40C. Portions of liver (lOg fresh wt.) were homogenized in 2vol. of SKMT buffer (0.25M-sucrose-
pH7.5). The homogenate was filtered through four layers of cheesecloth and a purified nuclear pellet was subsequently obtained as described above.
The supernatant from the 600g spin was centrifuged at 1lOOOOg for 90min in a Spinco 40 angle rotor. The supernatant from this spin is referred to as the cytosol fraction. Portions (5ml) of the cytosol fraction were subjected to gel filtration on columns (2cmx80cm) of Sephadex G-25 previously equilibrated with SKMT buffer, elution being carried out with the same solution. Fractions (3ml) were collected at a flow rate of 1 ml/min. The extinction of the eluate at 254nm was continuously monitored by using an LKB Infracord instrument. The radioactivity of the eluted fractions was determined by placing 0.5ml samples directly into lOml of the dioxan-based scintillator.
Portions (0.5ml) of the column-excluded labelled fractions, obtained after passage of cytosol through Sephadex G-25 columns, were subjected to centrifugation on sucrose density gradients. Linear sucrose gradients [5 ml, 5-20% (w/v) sucrose] were prepared by hand in 1 mM-f-mercaptoethanol-1 mM-EDTA-0.5mM-MgCl2 -O.OM-tris -HCl buffer, pH8.0 (MEMT buffer). After samples (0.5 ml) of the labelled macromolecular cytosol fraction had been layered on top of the gradient, the gradients were centrifuged at 36000rev./min in a Spinco SW 39 rotor at 4°C for 16.5h. After removal from the rotor, the bottoms of the tubes were pierced and fractions collected directly in radioactivity-counting vials by means of counting drops. Some 10-12 equal fractions were collected, and their radioactivity was determined after addition of lOml of dioxan-based scintillator.
Nuclei, isolated from livers of animals treated with [3H]cortisol, were extracted with MEMT buffer. MEMT buffer (2ml) containing 0.6M-NaCl was added to the nuclear pellet, and the suspension was stirred for 1 h in an ice bath. The viscous solution was centrifuged for 30min at 20000g in a Spinco SW 39 rotor at 40C. The supematant was carefully removed, and portions (1 ml) were applied to a column (2cm x 20cm) of Sephadex G-25 that had previously been equilibrated with the MEMT buffer containing 0.3M-NaCl. The column was developed with the same solution. A flow rate of 1 ml/min was maintained and 3 ml fractions were collected. The extinction at 254nm of the eluate was continuously monitored by using an LKB Infracord instrument. The radioactivity of the eluted fractions was determined after addition of portions (0.5ml) to lOml of dioxan-based scintillator.
Determination of thermal hyperchromicity (Tm) of chromatin and DNA Chromatin was prepared from isolated nuclear preparations by a modification of the method detailed by Mainwaring et al. (1971) , all procedures being carried out at 0-40C. Nuclei (isolated from 4g of tissue) were washed successively, once with 15ml of 0.2% Triton X-100, twice with 15ml of 80mM-NaCl-20mM-EDTA adjusted to pH6.3 with sodium citrate, and once with 15ml of 1.5mM-NaCl15mM-sodium citrate buffer, pH7.0. The final chromatin pellet was dispersed in water by gently homogenizing by hand in a Dounce all-glass homogenizer. Determinations of thermal hyperchromicity were carried out as described by Geiduschek (1962) for the 'd' assay (an assay which indicates the dissociation of base pairs). Assays were carried out in a Unicam SP. 800 spectrophotometer fitted with an electrically heated cell-holder. Samples' temperatures were measured by means of a thermocouple inserted into the spectrophotometer cell. The chromatin solutions were prepared in 0.25mM-EDTA, pH8.0. This lowionic-strength solution was used to magnify the difference in 'melting' profile between free DNA and chromatin (Bonner et al., 1968) . Purified DNA was prepared from the chromatin essentially by the method of Marmur (1963) . The DNA finally obtained was dissolved in 0.25mM-EDTA, pH 8.0. Determinations of thermal hyperchromicity were carried out on the DNA solutions as described by Geiduschek (1962) for both the 'd' and 'i' assays (the 'i' assay gives a measure of the irreversibility of denaturation).
Results
Tryptophan pyrrolase activity
Although the inhibitory effect of aflatoxin B1 on the induction of tryptophan pyrrolase by cortisol is well authenticated (Wogan & Friedman, 1968; Clifford & Rees, 1967a) , in view of its importance in the present work it was considered necessary to demonstrate the inhibition in the strain of rat to be used in this study. An experiment was therefore carried out to demonstrate this inhibition. The results indicated that in contrast to the control enzyme activity the cortisol-induced enzyme activity was strongly inhibited (>80%) by aflatoxin B1 administered in vivo (3.5mg/kg injected intraperitoneally in 0.05ml of dimethylsulphoxide).
RNA polymerase activity assayed in vitro
In an initial experiment the effect of various dosages of aflatoxin B1 on Mg2+-and Mn2+-activated RNA polymerase activity was determined. The results ofthis experiment are given in Fig. 1 . Maximal inhibition (approx. 70 %) was obtained with dosages of 2.5mg/kg and above. The rate of development of the inhibition was also determined (Fig. 2) . RNA polymerase activities *, Mg2+ assays; o, Mn2+-(NH4)2SO4 assays. Aflatoxin B1 was administered in a total volume of 0.1 ml of dimethyl sulphoxide, and the animals were killed 3h after dosing. Nuclei were prepared from pooled livers from groups of three animals.
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The effect of administration of aflatoxin B1 on the RNA polymerase activities in control and cortisolstimulated animals was examined. Both Mg2+-and Mn2+-(NH4)2SO4-stimulated RNA polymerase activities were assayed. The RNA polymerase activities found in the nuclei are indicated in Table 1 . The results indicate that increased RNA synthesis, resulting from the administration of cortisol, is observed in the Mg2+-stimulated assays but not in the Mn2+-(NH4)2SO4-stimulated assays. They show that the stimulated Mg2+-activated RNA synthesis resulting from cortisol administration is also inhibited by aflatoxin Bl. Also included in Table 1 Groups of three rats were injected intraperitoneally with (a) 0.05ml of dimethylsulphoxide and 1 ml of saline, (b) aflatoxin B1 (3.5mg/kg) in .05ml of dimethyl sulphoxide and 1 ml of saline, (c) 0.05ml of dimethyl sulphoxide and cortisol acetate (50mg/kg) in 1 ml of saline, or (d) aflatoxin B1 (3.5mg/kg) in 0.O5ml of dimethyl sulphoxide and cortisol acetate (50mg/kg) in 1 ml of saline. Animals were killed and livers removed 4h after injection. Duplicate nuclear preparations were obtained from pooled livers. Assays of polymerase activity were carried out in triplicate on each nuclear preparation. Dependence on the presence of all four nucleotides was checked in each experiment by omission of ATP, GTP and CTP. Activity in assays in which these nucleotides were omitted was less than 10 % of that with the complete system. Animals were killed 20min later and the cytosol fractions prepared as described in the Materials and Methods section. Portions of cytosol fractions from control (o-o) and aflatoxin-treated animals (e-----) with equal radioactive contents were subjected to gel filtration on Sephadex G-25. Fractions (3 ml) were collected and the radioactivity was determined on 0.5 ml portions of each fraction. extract was passed through a Sephadex G-25 column (Fig. 4) . In view of the results of these experiments it appeared that aflatoxin B1 at a dosage that maximally inhibited RNA synthesis neither affected the total uptake of [3H]cortisol into the nuclear or cytosol fractions, nor the extent of macromolecular binding of radioactivity within these fractions.
Soltubilized RNA polymerase activity RNA polymerase activity was solubilized from isolated control hepatic nuclei, and the activity was compared with that of enzyme solubilized from nuclei from rats pretreated with aflatoxin B1 and/or cortisol acetate (Table 5) . It did not appear that the activities of the salt-extractable RNA polymerase enzymes reflected the inhibitions observed in the RNA polymerase activities of intact nuclei after treatment with aflatoxin. Addition of aflatoxin B1 to the assay system, in contrast to actinomycin D, was without effect on the enzyme activity.
'Melting' profiles of chromatin and DNA The 'melting' profiles of chromatin and DNA, prepared from hepatic nuclei isolated from control and aflatoxin-treated rats, were examined by using the techniques described in the Materials and Methods section. The 'melting' profiles observed with the chromatin fractions are given in Fig. 5 . It appeared that the thermal 'melting' characteristics of chromatin were not altered by prior administration of a dose of aflatoxin B1 that would maximally inhibit nuclear RNA synthesis. The 'melting' profiles of the DNA similarly showed no change caused by the administration of aflatoxin B1. The 'melting' profiles of the DNA solutions were similar to those reported by Bonner et al. (1968) .
Vol. 130 Fraction'no. Fig. 4 . Fractionation of labelled nuclear extract oil Sephadex G-25 Labelled nuclei were prepared after treatment with [3 H]cortisol as described in Fig. 3 . Nuclei were extracted with buffered saline as detailed in the Materials and Methods section and portions of extracts, prepared from nuclei isolated from control ( o~o ) and aflatoxin-treated animals (-----*) with equal radioactive contents, were applied to Sephadex G-25 columns. Fractions (3 ml) were collected and the radioactive content of0.5 ml portions of the fractions was determined. RNA synthesis in nuclei isolated from animals treated with cortisol and aflatoxin was greater than that in nuclei isolated from animals treated with the toxin alone (Tables 1 and 2 ). The activity in the high-salt-Mn2+-activated assays, although inhibited by aflatoxin B1, was not stimulated by the treatment with cortisol in vivo. Increased RNA polymerase activity in low-salt, but not in high-salt, assay systems is a commonly observed feature in nuclei of target organs isolated from hormonally stimulated animals (Tata, 1967) . The inhibitory effect of aflatoxin B1 on the cortisol-induced increase in tryptophan pyrrolase activity, but not on the control value of the enzyme activity, is paralleled by the effect of the toxin on the incorporation of labelled leucine in vivo. In summary these results could be interpreted as indicating that aflatoxin B1 inhibits the stimulatory action of cortisol on hepatic nuclear RNA synthesis, and that consequent to this initial action there is an inhibition of cortisol-stimulated protein synthesis, of which synthesis of the enzyme tryptophan pyrrolase is a component. The lack of effect of the toxin on control values of amino acid incorporation may indicate that the latter process is dependent either on the aflatoxin-resistant RNA synthesis for a supply of the necessary ribonucleic acids or that longer-lived messenger RNA is involved. The relationship between aflatoxin action and the stimulation by cortisol of hepatic nuclear RNA synthesis was further indicated by the results of the experiment with adrenalectomized animals. Adrenalectomy resulted in a decreased Mg2+-dependent RNA polymerase activity being observed in the isolated nuclei, but this decrease and the inhibitory effect of aflatoxin B1 were not additive. It therefore appeared that the part of the RNAVol. 130 synthesizing mechanism that was inhibited by aflatoxin B1 included the sites that were normally activated by endogenous corticosteroid. The extent of maximal inhibition of RNA polymerase activity consistently observed in the present study (70%) is close to that observed by Pong & Wogan (1970) . This result indicates that approx. 30% of the RNAsynthesizing mechanism in rat liver nuclei is resistant to the action of aflatoxin B1. Whether this result is due to the total inhibition of RNA synthesis in 70 % of the nuclei present in the nuclear preparation, or is due to a 70% inhibition of the enzymic activity in individual nuclei (or something in between these two extremes) is obviously of great importance.
With regard to mechanisms by which aflatoxin B1 could possibly inhibit the stimulatory action of cortisol on hepatic nuclear RNA synthesis, the work of Williams & Rabin (1969) has shown that at the level of the endoplasmic reticulum, competition for binding sites can take place between aflatoxin B1 and certain steroid hormones. A similar mechanism could account for the inhibition by the toxin of cortisolstimulated nuclear events. It should be pointed out that Williams & Rabin (1969) found cortisol to be non-effective in their system, but this could presumably indicate a predominantly nuclear role for this steroid hormone. The mechanism of action of corticosteroids in hepatic cells has been extensively studied, and, in common with the mechanism of action of other steroid hormones in their respective target organs, it has been suggested that corticosteroids enter the nucleus in two stages, first by attachment to a macromolecular receptor in the cytosol fraction, and then, presumably by transfer of this complex through the nuclear membrane, a macromolecular-corticosteroid complex is subsequently observed in the nucleus (Beato et al., 1969) . These workers report that although cortisol is extensively metabolized in rat hepatic tissue, the fraction that enters the nucleus is almost exclusively unmetabolized cortisol. In the present study no attempt was made to characterize the labelled compounds present in the fractions after the administration of [3H]cortisol. One mechanism by which certain antagonists of steroid-hormone action have been shown to exert their anti-hormonal effect in the target organ is by attachment to steroid receptor macromolecules, either in the cytosol or nucleus, thereby blocking the uptake of the hormone into the chromatin and preventing the increased synthesis of RNA which normally accompanies hormonal stimulation (Belham & Neal, 1971) . In the present study, however, no effect on the macromolecular binding of label after the administration of [3H]cortisol was observed in the nuclear or cytosol fractions when animals were previously given a dose of aflatoxin B1 that was known to result in a maximal suppression of RNA synthesis. It is concluded therefore that the inhibitory 627 0 so IM w I action ofaflatoxin B1 on cortisol-stimulated processes is unlikely to be due to an exclusion of cortisol or an active metabolite of cortisol from binding sites present on soluble receptor substances.
The results obtained with solubilized RNA polymerase (Table 5) indicate that the effect of the toxin is not on the activity of the polymerase enzyme itself, and by inference it would appear probable that its action is on the chromatin template. Dissociation of an enzyme-inhibitor complex could possibly have occurred during extraction of the enzyme, but the stability ofthe inhibition in disrupted nuclei even after prolonged dialysis (G. E. Neal, unpublished work) indicates that this is an unlikely explanation. Edwards & Wogan (1970) have also produced evidence indicating that the activities of RNA polymerase enzymes present in aflatoxin-inhibited rat liver nuclei are not inhibited. These workers have also produced evidence which they claim demonstrates a decreased chromatin template capacity after pretreatment of the animals with aflatoxin. However, it would appear that this claim could be open to two possible objections. First, the RNA polymerase enzyme that they used (similar to that in the present study) was solubilized by extracting the nuclei in low-salt conditions, and this has been shown by to result almost exclusively in the solubilization of type I (nucleolar) enzyme, which Butterworth et al. (1971) have shown to be virtually inactive in the transcription ofmammalian chromatin. Secondly, the assay conditions used by Edwards & Wogan (1970) included high-salt concentrations, and these would result in endogenous RNA polymerase present in the chromatin templates used being maximally active. It would therefore appear that further experimentation examining the priming by chromatin templates of the activities of the individual species of RNA polymerase enzymes under a variety of assay conditions is necessary before it can be concluded with certainty that the toxin affects the template capacity of chromatin.
With regard to the mechanism of action of the cortisol, there has been a considerable diversity of opinion as to whether the stimulatory action of corticosteroids on RNA synthesis in hepatic nuclei is due to an effect of the hormone on the activity of polymerase enzymes, template capacity or both (Dahmus & Bonner, 1965; Yu & Feigelson, 1971) . Blatti et al. (1970) have demonstrated an increase in the activity of nucleolar polymerase enzyme after the administration of glucocorticoid to adrenalectomized rats. In the present study, an increased solubilized polymerase activity was observed when nuclei from cortisol-treated rats were used (Table 5) , and in view of the solubilization technique used, this was presumably due to an increased activity of nucleolar enzyme. This increased polymerase activity was still evident after aflatoxin B1 administration. If, as discussed above, the inhibitory effect of aflatoxin B1 is predominantly on the template, then that fraction of the enhanced RNA synthesis which is due to increased activity ofpolymerase enzyme should not be inhibited by the toxin. This could account for the fact that Mg2+-activated RNA polymerase activity in intact nuclei isolated from rats treated with cortisol and aflatoxin B1 was always greater than that in nuclei isolated from rats treated with aflatoxin B1 alone.
If aflatoxin B1 administered in vivo affects the capacity of the chromatin template for RNA synthesis, then the experiments carried out in the present study indicate that this does not involve changes readily detected by 'melting'-profile assays. Binding of aflatoxin B1 to DNA in vitro has been observed (Sporn et al. 1966; Clifford & Rees, 1967b) , but the binding is weak, and in contrast to the binding of actinomycin D to DNA, does not survive passage through a gel-filtration column. Also, if simple binding of aflatoxin B1 to DNA accounted for its inhibitory action on RNA synthesis, then it is difficult to explain the non-effectiveness of aflatoxin B1 when added to RNA-synthesizing systems in vitro, either intact nuclei (Edwards & Wogan, 1970) or isolated RNA polymerase enzyme-DNA mixtures (King & Nicholson, 1967 ; see also Table 5 ). Clearly the uptake and distribution of aflatoxin B1 within the hepatic cell requires further detailed study before its inhibitory action on RNA synthesis can be fully explained.
